Skip to main content


Our approach to Continuous Professional Development

Our approach to Continuous Professional Development of Healthcare Professionals (HCPs)


At Janssen, we believe that sponsoring and supporting Continuous Professional Development (CPD) programmes (also known as Continuous Medical Education or CME) for HCPs is part of our responsibility for the medicines we develop. By increasing knowledge about diseases and the latest standards of care and treatments, we can help to enhance medical practice as well as improve patient outcomes.

Through our CPD programmes we aim to contribute to high quality education in true partnership with the medical community, to ensure that important new medical advances are discussed in a variety of settings from international congresses to smaller educational meetings. Strict company principles ensure that this happens in an unbiased way and is transparent about our interactions with individual HCPs, as well as those with medical societies and institutions.

At Janssen, we focus on three types of activity:    

1-Congress support:

We provide financial support in the form of grants and sponsorships to the major national and European congresses. This is because congresses provide HCPs with critical information on medical advances, essential for improving patient care. 

The educational meetings we support must foster scientific exchange and disseminate latest standard of care to help facilitate safe and effective treatment for patients. Some of these meetings are qualified by accreditation bodies, and some are not. At Janssen, we apply the same quality rules to both.

At a local level, Janssen follows the national regulations in regards to events accreditation and health authority endorsement.


2-Medical education programmes:

We support medical educational events and activities which are organised with independent experts according to Janssen principles. The policy Janssen follows is based on the Association of the British Pharmaceutical Industry (ABPI) Code of Practice on the promotion of prescription-only medicines and interactions with HCPs. Further information on the Code is available from the ABPI.


3-Individual support:

We provide support for individual HCPs to attend congresses and meetings. HCPs have a responsibility to keep up to date with medical advances through continued education, along with other pharmaceutical companies; Janssen is taking part of the responsibility here. The selection process for Janssen is transparent and based on HCPs educational needs or active involvement in a meeting or event.

We are confident that the Janssen Way of supporting CPD programmes meets society’s expectations in terms of transparency, whilst fostering scientific exchange and knowledge dissemination to ensure the best treatment outcomes for patients.



CP-322388 | June 2022